NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









GFBiochemicals

GFBiochemicals

Private
Aix-en-ProvenceEnergy & Sustainabilityhttps://www.gfbiochemicals.com/

Last Round

Series A

May 4, 2022

Total Funding Raised

$15.82M

Company Overview

GFBiochemicals is a specialty chemicals company that develops and manufactures sustainable, plant-based levulinic acid and its derivatives to replace petrochemical ingredients in industrial and consumer applications.

Sector

Energy & Sustainability

Verticals

Sustainable Materials, Clean Manufacturing, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

levulinic acidbio-based chemicalsgreen chemistrysustainable solventsbio-based plasticizersCASE industrycoatings adhesives sealantsdrop-in chemicalsspecialty chemicalsbiomass conversionsustainable materialsclean manufacturingbio-economyESG compliance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GFBiochemicals Comparables

Compare GFBiochemicals with similar companies based on industry and business-model similarity.

GFBiochemicals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Circa Group
78%
P2 Science Inc.
76%
Relement
74%

GFBiochemicals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 4, 2022

Key People

Founding team and executive leadership

Henri Lefebvre

CFO

Executive Team

Louis Neltner

Chief Operating Officer

Executive Team

Sergio Vieira

Chief Operating Officer

Executive Team

GFBiochemicals Investors

Notable investors and investment history

GFBiochemicals investors
InvestorRounds
Sofinnova PartnersSeries A
Sparta Capital ManagementSeries A

GFBiochemicals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GFBiochemicals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GFBiochemicals's valuation, stock price, and market status.

Firmographic Details

HeadquartersAix-en-Provence
Employee Range40
Year Founded2008
Last FundingMay 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.